This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barrett BJ and Parfrey PS (2006) Preventing nephropathy induced by contrast medium. N Engl J Med 354: 379–386
Aspelin P et al. (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348: 491–499
Barrett BJ et al. (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double blind comparison of iodixanol and iopamidol. Invest Radiol 41: 815–821
Jo SH et al. (2006) Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 48: 924–930
Pannu N et al. (2006) Prophylaxis strategies for contrast-induced nephropathy. JAMA 295: 2765–2779
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author has received a consulting fee and speaker's honoraria from GE Medical.
Rights and permissions
About this article
Cite this article
Murray, P. Risk of contrast-induced nephropathy in patients with normal renal function: iso-osmolar versus low-osmolar medium. Nat Rev Nephrol 3, 306–307 (2007). https://doi.org/10.1038/ncpneph0490
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0490